0001799191-22-000056.txt : 20221208 0001799191-22-000056.hdr.sgml : 20221208 20221208190226 ACCESSION NUMBER: 0001799191-22-000056 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20221207 FILED AS OF DATE: 20221208 DATE AS OF CHANGE: 20221208 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Virnich Daniel CENTRAL INDEX KEY: 0001891107 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39248 FILM NUMBER: 221453458 MAIL ADDRESS: STREET 1: C/O THE ONCOLOGY INSTITUTE OF HOPE STREET 2: 18000 STUDEBAKER ROAD, SUITE 800 CITY: CERRITOS STATE: CA ZIP: 90703 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Oncology Institute, Inc. CENTRAL INDEX KEY: 0001799191 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-OFFICES & CLINICS OF DOCTORS OF MEDICINE [8011] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 18000 STUDEBAKER RD STREET 2: SUITE 800 CITY: CERRITOS STATE: CA ZIP: 90703 BUSINESS PHONE: 562-735-3226 MAIL ADDRESS: STREET 1: 18000 STUDEBAKER RD STREET 2: SUITE 800 CITY: CERRITOS STATE: CA ZIP: 90703 FORMER COMPANY: FORMER CONFORMED NAME: DFP HEALTHCARE ACQUISITIONS CORP. DATE OF NAME CHANGE: 20200108 4 1 edgardoc.xml PRIMARY DOCUMENT X0306 4 2022-12-07 0 0001799191 Oncology Institute, Inc. TOI 0001891107 Virnich Daniel C/O THE ONCOLOGY INSTITUTE INC. 18000 STUDEBAKER RD, SUITE 800 CERRITOS CA 90703 0 1 0 0 President Common Stock 2022-12-07 4 M 0 175000 0.86 A 448585 D Common Stock 2022-12-07 4 M 0 175000 0.86 A 623585 D Non-Qualified Stock Option (right to buy) 0.86 2022-12-07 4 M 0 175000 0.0 D 2030-03-01 Common Stock 175000 829609 D Non-Qualified Stock Option (right to buy) 0.86 2022-12-07 4 M 0 175000 0.0 D 2030-03-01 Common Stock 175000 654609 D These options vest monthly for 36 months following November 12, 2021, the date of the closing of the Business Combination. These options vest as to 1/4th of the total number of shares subject to the option on the first anniversary of March 1, 2020 (the "Original Grant Date"), and as to 1/36th of the total number of shares monthly thereafter, such that 100% of the shares subject to the option will be fully vested on the fourth anniversary of the Original Grant Date, subject to continued employment through the vest date. By: Mark Hueppelsheuser For: Daniel Virnich 2022-12-08